Source: Cision Canada

Press Release: Pharmascience : Pharmascience Canada launches Pr pms-PALBOCICLIB, a treatment for breast cancer

/CNW/ - Pharmascience Canada is pleased to announce the launch of Pr pms-PALBOCICLIB. About Pr pms-PALBOCICLIB: Pr pms-PALBOCICLIB (palbociclib) is a...

Read full article »

Pharmascience's Competitors | Pharmascience's News | Pharmascience's Financials

Followers on Owler

252

Est. Annual Revenue

$500M-1.0B

Est. Employees

1.0-5.0K

CEO

Martin Arès

CEO Approval Rating

82/100

Pharmascience is a Canada-based pharmaceutical company that develops and commercializes generic drugs and over-the-counter products for the healthcare industry.